The Growing Impact of Weight-Loss Drugs on U.S. Obesity Rates
Introduction
In recent years, new weight-loss drugs like Ozempic and Wegovy have sparked significant interest and debate in the U.S. for their role in obesity management. These medications, originally designed to treat type 2 diabetes, have now gained attention for their ability to help individuals shed pounds and sustain weight loss. However, the long-term effects and broader implications for public health are still being evaluated, with mixed opinions on whether these drugs can lead to sustained reductions in U.S. obesity rates.
